Late onset GM2 gangliosidosis presenting with motor neuron disease: An autopsy case

Adult‐onset GM2 gangliosidosis is very rare and only three autopsy cases have been reported up to now. We report herein an autopsy case of adult‐onset GM2 gangliosidosis. The patient developed slowly progressive motor neuron disease‐like symptoms after longstanding mood disorder and cognitive dysfunction. He developed gait disturbance and weakness of lower limbs at age 52 years. Because of progressive muscle weakness and atrophy, he became bed‐ridden at age 65. At age of 68, he died. His neurological findings presented slight cognitive disturbance, slight manic state, severe muscle weakness, atrophy of four limbs and no extrapyramidal signs and symptoms, and cerebellar ataxia. Neuropathologically, mild neuronal loss and abundant lipid deposits were noted in the neuronal cytoplasm throughout the nervous system, including peripheral autonomic neurons. The most outstanding findings were marked neuronal loss and distended neurons in the anterior horn of the spinal cord, which supports his clinical symptomatology of lower motor neuron disease in this case. The presence of lipofuscin, zebra bodies and membranous cytoplasmic bodies (MCB) and the increase of GM2 ganglioside by biochemistry led to diagnosis of GM2 gangliosidosis.

[1]  Yoon-Ho Hong,et al.  A mutation of HEXB gene in Sandhoff disease presenting as motor neuron disease. , 2010, Neurology India.

[2]  M. Zwarts,et al.  New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  A. Oliveira,et al.  Late-onset hexosaminidase A deficiency mimicking primary lateral sclerosis. , 2009, Arquivos de neuro-psiquiatria.

[4]  M. Kornfeld Neuropathology of chronic GM2 gangliosidosis due to hexosaminidase A deficiency. , 2008, Clinical neuropathology.

[5]  B. Banwell,et al.  The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported , 2006, Pediatrics.

[6]  Lauren C. Frey,et al.  The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. , 2005, Archives of neurology.

[7]  M. G. Cusella De Angelis,et al.  Restoration of the GM2 Ganglioside Metabolism in Bone Marrow–Derived Stromal Cells from Tay-Sachs Disease Animal Model , 2002, Neurochemical Research.

[8]  A. Orlacchio,et al.  Absence of Metabolic Cross-correction in Tay-Sachs Cells , 2002, The Journal of Biological Chemistry.

[9]  Kinuko Suzuki Neuropathology of Late Onset Gangliosidoses , 1991 .

[10]  D. Mahuran,et al.  Biochemistry and Genetics of Tay-Sachs Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[11]  I. Rapin,et al.  Juvenile GM2‐gangliosidosis , 1970, Neurology.

[12]  K. Sandhoff 8. The GM2-gangliosidoses and the elucidation of the β-hexosaminidase system , 2001 .

[13]  A. Tanaka [GM2 gangliosidosis]. , 2001, Ryoikibetsu shokogun shirizu.

[14]  K. Sandhoff The GM2-gangliosidoses and the elucidation of the beta-hexosaminidase system. , 2001, Advances in genetics.

[15]  G. MacQueen,et al.  Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[16]  K. Suzuki,et al.  Neuropathology of late onset gangliosidoses. A review. , 1991, Developmental neuroscience.

[17]  K. Jellinger,et al.  Adult GM2 gangliosidosis masquerading as slowly progressive muscular atrophy: motor neuron disease phenotype. , 1982, Clinical neuropathology.